Hideki Hoshino

Apparent per-session removal of AQP4-IgG during therapeutic plasma exchange in a patient with aquaporin-4 antibody–positive neuromyelitis optica spectrum disorders: a case report

Shinya Tomori, Kazuhiro Takahashi, Norio Hanafusa, Hideaki Mashimo et autres

Abstract Therapeutic plasma exchange (TPE) is an established treatment for neuromyelitis optica spectrum disorders (NMOSD) that removes pathogenic aquaporin-4 antibodies (AQP4-IgG). We present the case of a 15-year-old boy with AQP4-IgG–positive NMOSD who underwent six TPE sessions. Quantitative analysis revealed mean removal …

jp (code pays fourni par la source)

Association between QTA30 scores and headache‐related assessments in children

Toshiyuki Hikita, Hideki Hoshino, Masakazu Mimaki

BACKGROUND: The QTA30 is a simple questionnaire used to assess physical and mental health in children. Headache-related disability and impact are commonly evaluated using the Pediatric Migraine Disability Assessment (PedMIDAS) and the Headache Impact Test-6 (HIT-6). This study examined the relationship between …

jp (code pays fourni par la source)

Pediatric Unilateral Optic Neuritis Associated with Double-Positive Anti-Myelin Oligodendrocyte Glycoprotein and Anti-N-Methyl-D-Aspartate Receptor Antibodies: A Case Report and Literature Review

Shunsaku Nakai, Seima Iwai, Hideki Hoshino, Hiroshi Sakuma et autres

A 13-year-old Japanese boy was admitted to hospital with tonic-clonic seizures. Brain magnetic resonance imaging (MRI) showed diffuse swelling of the gray matter and obscured cerebral sulci in the lateral part of the right cortex. He was treated with intravenous midazolam, diazepam, …

jp (code pays fourni par la source)

早期の入院加療を行った神経性やせ症制限型の1例からみる地域基幹病院での治療介入とその役割

嶋田 怜士, 高宮 聖美, 眞下 秀明, Hideki Hoshino et autres

West症候群を発症したPTEN病的バリアントの女児例

門田 茉莉, 占部 良介, 中井 まりえ, Hideki Hoshino et autres

体重増加不良を主訴に来院した乳幼児の臨床的検討

落合 悟, Hideki Hoshino, 大石 亜美, 落合 千春 et autres

Weekly ACTH療法により良好な発作コントロールと発達の促進を認めるGBS髄膜炎後West症候群の1例

落合 悟, Hideki Hoshino, 瑞穂 新戸, 眞下 秀明 et autres

Eculizumab in Adolescent Patients With Refractory Generalized Myasthenia Gravis: A Phase 3, Open-Label, Multicenter Study

John F. Brandsema, Matthew R. Ginsberg, Hideki Hoshino, Masakazu Mimaki et autres

BACKGROUND: This study evaluated the efficacy and safety of eculizumab, a terminal complement C5 inhibitor, in juvenile generalized myasthenia gravis (gMG). METHODS: Adolescents aged 12 to 17 years with refractory anti-acetylcholine receptor (AChR) antibody-positive gMG received eculizumab (weekly induction [one to two …

us, jp, ch (code pays fourni par la source)

けいれん重積で発症し,後に視神経炎を呈した抗NMDAR抗体陽性MOGADの1例

平野 桜子, Hideki Hoshino, 瑞穂 新戸, 占部 良介 et autres

難治性全身型重症筋無力症(gMG)小児患者を対象としたエクリズマブ第III相非盲検試験

Hideki Hoshino, Masakazu Mimaki, Tomohiro Nagata, 山内 秀雄

情動過敏を伴う自閉スペクトラム症に対するメラトニン製剤の有効性の検討

平野 桜子, Hideki Hoshino, 眞下 秀明, 中井 まりえ et autres

A case of costovertebral angle tenderness without urinary abnormality due to posterior pararenal space abscess

Tomohiko Nishino, Mizuho Niido, Satoru Ochiai, Hideki Hoshino et autres

The authors declare that they have no conflicts of interest. The data sets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.

jp (code pays fourni par la source)